C79.9
Secondary malignant neoplasm of unspecified site
Clinical Classification Guidelines
Inclusion Terms
- Metastatic cancer NOS
- Metastatic disease NOS
Excludes Type 1
- carcinomatosis NOS (C80.0)
- generalized cancer NOS (C80.0)
- malignant (primary) neoplasm of unspecified site (C80.1)
Medical Intelligence & Overview
Secondary malignant neoplasm of an unspecified site, classified under ICD-10 code C79.9, refers to cancer that has spread from its original location to other parts of the body, but without specifying the new location. This condition is also known as metastatic cancer, indicating the spread of malignant cells beyond the primary tumor. Metastatic disease can affect various organs and tissues, complicating treatment and prognosis. Understanding this diagnosis involves learning about how cancer spreads, common sites involved, symptoms, diagnostic procedures, and general treatment approaches.
Causes & Symptoms
Clinical Causes: Uncontrolled growth of primary cancer cells that invade nearby tissues and enter the bloodstream or lymphatic system Genetic mutations within cancer cells that enable they to invade distant sites Lack of early detection and treatment of primary cancer, allowing it to progress and metastasize Environmental factors such as exposure to carcinogens Lifestyle factors including smoking, poor diet, and lack of physical activity
Key Symptoms: Unexplained fatigue and weakness Weight loss and loss of appetite Pain in areas where metastases occur Swelling or lumps in particular regions Neurological symptoms like headaches, dizziness, or seizures if the brain is involved Visual disturbances if the eye or brain is affected Shortness of breath or cough if lungs are involved Hormonal changes if endocrine glands are affected
Diagnostic & Treatment
Diagnosis Path: Diagnosis of secondary malignant neoplasm involves several steps:
Treatment Protocols: Treatment options for metastatic cancer depend on the primary cancer type, extent of spread, and overall health of the patient:
Clinical Advice & FAQs
Billing Guidance
Is C79.9 a billable ICD-10 code?
Yes, C79.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.9?
Clinical documentation must specify the nature of Secondary malignant neoplasm of unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference